Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
Healthcare
Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jun 21, 2024 10:13am
NOTHING FROM BIOV WHEN THE LONG HALT WILL END/BAD SIGN
I am very worried no updates or promise of when it will start trading or any improvment... ????? concerned shareholder. glta
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 21, 2024 1:19pm
I am interested in people's opinion on the this"furthe"delay
If anyone has been in biov for longtime, and follow it closely have an opinion, share your thoughts.. glta
(76)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on May 17, 2024 9:43am
RE:Prev Biov requested cto now its osc issuing it, losing faith
SORRY FOR MY TYPOS! I MEANT TO SAY , MY TRUST IN THIS BEHAVIOUR HAS CHANGED. SOMTHING IS QUESTIONABLE HERE..
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 17, 2024 9:32am
Prev Biov requested cto now its osc issuing it, losing faith
now i feel differently after osc issued it due to them failing to file. why have they failed they had enough time unless somthing is fishy..l my trust in this behaviour has changed. I hope biov
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 16, 2024 12:15pm
New Press Release - BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
VANCOUVER, BC, May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities Commission (the "OSC") has issued a failure to file cease trade order ("FFCTO") under National Policy 11-207 Failure-to-File Cease...
read article.
(298)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on May 16, 2024 10:57am
BIOV~MY ASK ORDER @.29 WAS INSTANTLY CANCELLED @HALT START
WHY?> ANYONE KNOW?????????? 18 minutes ago @arioch am i missing something, or has that cibc ask been removed? privilege... 0 17 minutes ago
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 16, 2024 10:22am
New Press Release - CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)
Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2024) - Effective immediately, BioVaxys Technology Corp. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 16, 2024 7:42am
New Press Release - Canadian Investment Regulatory Organization Trading Halt - BIOV
VANCOUVER, BC, May 16, 2024 /CNW/ - The following issues have been halted by CIRO:Company: BioVaxys Technology Corp.CSE Symbol: BIOVAll Issues: YesReason: Cease Trade OrderHalt Time (ET): 7:33 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 10, 2024 5:50pm
New Press Release - BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
// THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES //VANCOUVER, BC, May 10, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 03, 2024 6:34pm
New Press Release - BioVaxys Technology Corp. Closes First Tranche of Private Placement
// THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES //VANCOUVER, BC, May 3, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously...
read article.
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 02, 2024 9:38am
MCTO DATE
in This paragraph, I am not clear if they're saying they need additional time beyond may 13 or they anticipate it by may 13? how do others understand this statement? The Company
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 02, 2024 9:02am
New Press Release - BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
VANCOUVER, BC, May 2, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the "MCTO"), by its principal regulator, the Ontario Securities...
read article.
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 01, 2024 11:35am
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses..
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 by @newswire on 1 May 2024, 10:05 USA News Group Commentary Issued on behalf of BioVaxys
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 30, 2024 8:01am
New Press Release - BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER
VANCOUVER, BC, April 30, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has appointed Christopher Cherry as Chief Financial Officer. Mr. Cherry, a Chartered Accountant and Certified Public Accountant, has...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Why Dozens of Pro Athletes are Paying Attention to this Product
Q Precious & Battery Metals To Resume Diamond Drilling La Corne South Project, Val D'or Quebec
Webinar Dec. 12, 2024: Transforming Regenerative Medicine. Register Now